Richter launches Forsteo biosimilar in EU
admin 21st August 2019 Uncategorised 0Both products are approved in adults for osteoporosis in various indications. More: Richter launches Forsteo biosimilar in EU Source: News
read moreBoth products are approved in adults for osteoporosis in various indications. More: Richter launches Forsteo biosimilar in EU Source: News
read moreThe injection was made as the last two decades have witnessed dramatic, unpredicted changes in fertility levels. More: £708,000 granted for fertility research Source: News
read moreThe ‘life-changing’ drug will be reimbursed for certain people with severe congenital haemophilia A. More: NHS to reimburse Hemlibra Source: News
read moreThe drug giant reported that in the primary analysis population the combination did not meet the primary endpoint. More: AZ’ Imfinzi combo fails lung cancer study Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals